Quarterly JM Medical News

Understanding Second-Line Treatments and Side Effects

Second-line treatments refer to options beyond steroids and methotrexate. They are designed to manage JM while reducing reliance on those medications. We understand that adding new treatments to your child’s regimen can be intimidating. However, rest assured that your doctor has carefully considered the benefits and risks of each option to design the best treatment plan for your family.

Early Promising Data Presented in Car-T for Myositis

Cabaletta Bio Presents Promising Early Data on CAR-T Therapy for Myositis

We expected to hear promising news about the potential for CAR-T therapy to treat myositis at the Global Conference on Myositis (GCOM).

What we heard was more than promising—it was astounding.

What if I told you that there was a therapy that would “reset” the immune system—virtually eliminating the autoimmune response in myositis that causes inflammation, pain, muscle weakness, and other JM conditions of which we are all too familiar.

Optimizing Myositis Care: The Role of Biologics

Biologics are a therapies that derived from living cells or through biological processes. They are a promising new class of drugs used to treat myositis.

Understanding Second-Line Treatments and Side Effects

Cabaletta Bio Presents Promising Early Data on CAR-T Therapy for Myositis

Optimizing Myositis Care: The Role of Biologics

Join Cure JM

Families

Physicians

Cure JM

Get Involved

Interested in DIY fundraising but need help?

We’re here to help!